Diterpenes from Euphorbia as potential leads for drug design

Natural Product Communications

Volumn 3, Issue 6, 2008, Pages 1003-1020

  Barile, Elisa ^a   Corea, Gabriella ^a   Lanzotti, Virginia ^a  

^a UNIVERSITY OF MOLISE   (Italy)

Author keywords

Anti inflammatory activity; Diterpenes; Euphorbia; Jatrophane; MDR activity; Paraliane; Pepluane; Segetane

Indexed keywords

ABEODENDROIDIN F; AMYGDALOIDIN A; AMYGDALOIDIN B; AMYGDALOIDIN C; AMYGDALOIDIN D; AMYGDALOIDIN E; AMYGDALOIDIN F; AMYGDALOIDIN G; AMYGDALOIDIN H; AMYGDALOIDIN I; DITERPENOID; EPIABEODENDROIDIN F; EUPHODENDROIDIN A; EUPHODENDROIDIN B; EUPHODENDROIDIN C; EUPHODENDROIDIN D; EUPHODENDROIDIN E; EUPHODENDROIDIN F; EUPHODENDROIDIN G; EUPHODENDROIDIN H; EUPHODENDROIDIN I; EUPHORBIA EXTRACT; PEPLUANE DITERPENE; PEPLUANONE; TERRACINOLIDE B; TERRACINOLIDE C; TERRACINOLIDE J; TERRACINOLIDE K; TERRACINOLIDE L; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACYLATION; ANTIINFLAMMATORY ACTIVITY; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DEUTERON NUCLEAR MAGNETIC RESONANCE; DOWN REGULATION; DRUG DESIGN; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; EUPHORBIA; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; IN VIVO STUDY; LIPOPHILICITY; MACROPHAGE; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; STRUCTURE ACTIVITY RELATION;

EUPHORBIA; EUPHORBIA AMYGDALOIDES; EUPHORBIA CHARACIAS; EUPHORBIA DENDROIDES; EUPHORBIA PARALIAS; EUPHORBIA PEPLUS; MURINAE;

EID: 66449107317     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0800300629     Document Type: Review

References (42)

1. Pliny the Elder. Naturalis historia, XXVI, 45.
2. Lawant P, Winthagen D. (2001) Euphorbia resinifera portrayed in a manuscript herbal nearly fifteen hundred years ago. Bradleya, 19, 3-14.
3. Hohmann J, Molnár J, Rédei D, Evanics F, Forgo P, Kálmán A, Argay G, Szabó P. (2002) Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of multidrug resistance of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species. Journal of Medicinal Chemistry, 45, 2425-2431.
4. Corea G, Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Appendino G, Ballero M, Simon PN, Dumontet C, Di Pietro A. (2003) Jatrophane diterpenes as P-glycoprotein inhibitors. First insights of structure-activity relationships and discovery of a new, powerful lead. Journal of Medicinal Chemistry, 46, 3395-3402.
5. Juliano RL, Ling V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta, 455, 152-162.
6. Endicott JA, Ling V. (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry, 58, 137-171.
7. Gottesman MM, Pastan I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385-427.
8. Leveille-Webster CR, Arias IM. (1995) The biology of the P-glycoprotein. Journal of Membrane Biology, 143, 89-102.
9. Sharom FJ. (1997) The P-glycoprotein efflux pump: how does it transport drugs? Journal of Membrane Biology, 160, 161-175.
10. Scala S, Akhmed N, Rao US, Paull K, Lan LB, Dickstein B, Lee JS, Elgemeie GH, Stein W, Bates SE. (1997) The P-glycoprotein substrates and antagonists cluster into two distinct groups. Molecular Pharmacology, 51, 1024-1033.
11. Bolhuis H, van Veen HW, Poolman B, Driessen AJM, Konings WN. (1997) Mechanisms of multidrug transporters. FEMS Microbiology Review, 21, 55-84.
12. Higgins CF. (1994) P-glycoprotein. To flip or not to flip? Current Biology, 4, 259-260.
13. Robert J, Jarry C. (2003) Multidrug resistance reversal agents. Journal of Medicinal Chemistry, 46, 4805-4817.
14. Corea G, Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Appendino G, Ballero M, Simon PN, Dumontet C, Di Pietro A. (2003) Modified jatrophane diterpenes as modulators of multidrug resistance from Euphorbia dendroides L. Bioorganic and Medicinal Chemistry, 11, 5221-5227.
15. Corea G, Fattorusso E, Lanzotti V, Motti R, Simon PN, Dumontet C, Di Pietro A. (2004) Structure-activity relationships for euphocharacins A-L, a new series of jatrophane diterpenes, as inhibitors of cancer cell P-glycoprotein. Planta Medica, 70, 657-665.
16. Corea G, Fattorusso E, Lanzotti V, Motti R, Simon PN, Dumontet C, Di Pietro A. (2004) Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A. Journal of Medicinal Chemistry, 47, 988-992.
17. Corea G, Fattorusso C, Fattorusso E, Lanzotti V. (2005) Amygdaloidins A-L, twelve new 13α-OH jatrophane diterpenes from Euphorbia amygdaloides L. Tetrahedron, 61, 4485-4494.
18. Barile E, Lanzotti V. (2007) Biogenetical related highly oxygenated macrocyclic diterpenes from sea spurge Euphorbia paralias. Organic Letters, 18, 3603-3606.
19. Corea G, Fattorusso E, Lanzotti V, Di Meglio P, Maffia P, Grassia G, Ialenti A, Ianaro A. (2005) Discovery and biological evaluation of the novel natural occurring diterpene pepluanone as antiinflammatory agent. Journal of Medicinal Chemistry, 48, 7055-7062. (Pubitemid 41533127)
20. Barile E, Fattorusso E, Ialenti A, Ianaro A, Lanzotti V. (2007) Paraliane and pepluane diterpenes as anti-inflammatory agents: First insights in structure-activity relationships. Bioorganic & Medicinal Chemistry Letters, 17, 4196-4200.
21. Turner R. (1995) Euphorbias, B.T. Batsford Ltd, London.
22. Jakupovic J, Morgenstern T, Bittner M, Silva M. (1998) Diterpenes from Euphorbia peplus. Phytochemistry, 47, 1601-1609.
23. Hohmann J, Vasas A, Gunther G, Mathe I, Evanics F, Dombi G, Jerkovich G. (1997) Macrocyclic diterpene polyester of the jatrophane type from Euphorbia esula. Journal of Natural Products, 60, 331-335. (Pubitemid 27184906)
24. Appendino G, Jakupovic S, Tron GC, Jakupovic J, Milon V, Ballero M. (1998) Macrocyclic diterpenoids from Euphorbia semiperfoliata. Journal of Natural Products, 61, 749-756.
25. Marco JA, Sanz-Cevera JF, Yuste A, Jakupovic J, Jeske F. (1998) Jatrophane derivatives and rearranged jatrophane from Euphorbia terracina. Phytochemistry, 47, 1621-1630. (Pubitemid 28242188)
26. Marco JA, Sanz-Cervera JF, Yuste A, Jakupovic J, Lex J. (1996) Terracinolides A and B, two bishomoditerpene lactones with a novel carbon framework from Euphorbia terracina. Journal of Organic Chemistry, 61, 1707-1709. (Pubitemid 26107808)
27. Marco JA, Sanz-Cervera JF, Yuste A, Jakupovic J. (1997) Terracinolides from Euphorbia terracina, Phytochemistry, 45, 137-140.
28. Jakupovic J, Jeske F, Morgenstern T, Tsichritzis F, Marco JA, Berendshon W. (1998) Diterpenes from Euphorbia segetalis. Phytochemistry, 47, 1583-1600.
29. Marco JA, Sanz-Cervera JF, Yuste A, Jakupovic J. (1999) Isoterracinolides A and B, novel bishomoditerpene lactones from Euphorbia terracina. Journal of Natural Products, 62, 110-113. (Pubitemid 29071388)
30. Jakupovic J, Morgenstern T, Marco JA, Berendshon W. (1998) Diterpenes from Euphorbia paralias. Phytochemistry, 47, 1611-1619.
31. Madureira AM, Gyémánt N, Ascenso JR, Abreu PM, Molnár J, Ferreira MJU. (2006) Euphoportlandols A and B, tetracylic diterpene polyesters from Euphorbia portlandica and their anti-MDR effects in cancer cells. Journal of Natural Products, 69, 950-953. (Pubitemid 44166271)
32. Öksüz S, Gürek F, Shu-Wei Y, Long-Ze L, Cordell GA, Pezzuto JM, Wagner H, Lotter H. (1997) Paralinones A and B, novel diterpene esters from Euphorbia paralias. Tetrahedron, 53, 3215-3222. (Pubitemid 27087464)
33. Abdelgaleil SAM, Kassem MI, Doe M, Baba M, Nakatani M. (2001) Diterpenoids from Euphorbia paralias. Phytochemistry, 58, 1135-1139.
34. Jeske F. (1996) Ph.D. Thesis, Technische Universität of Berlin, Berlin, Germany.
35. Ialenti A, Ianaro A, Moncada S, Di Rosa M. (1992) Modulation of acute inflammation by endogenous nitric oxide. European Journal of Pharmacology, 211, 177-182.
36. Ianaro A, O'fDonnell C.A, Di Rosa M, Liew FY. (1994) A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology, 82, 370.
37. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P. (1994) Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences USA, 91, 12013-12017.
38. Salvemini D, Manning PT, Zwifel BS, Seibert K, Connor J, Currie MG, Needleman P, Masferrer JL. (1995) Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. The Journal of Clinical Investigation, 96, 301-308.
39. Mannel DN, Echtenacher B. (2000) TNF in the inflammatory response. Chemical Immunology, 74, 141-161.
40. Ghosh S, Karin M. (2002) Missing pieces in the NF-κB puzzle. Cell, 109, S81-S96.
41. Makarov SS. (2000) NF-κB as a therapeutic target in chronic inflammation: recent advances. Molecular Medicine Today, 6, 441-448.
42. Andreakos ET, Foxwell BM, Brennan FM, Marini RRN, Feldmann M. (2002) Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine & Growth Factor Reviews, 13, 299-313.